Julie Fischer is a USPTO-registered patent practitioner who helps life sciences innovators protect and strengthen high-value technologies through strategic patent preparation and prosecution. She coordinates with counsel to support patentability, invalidity, landscape, and freedom-to-operate (FTO) analyses and ex-U.S. prosecution.
With a Ph.D.-level technical background in molecular genetics, Julie brings deep scientific fluency to complex biologic and therapeutic platforms spanning genomics, diagnostics, pharmaceuticals, and laboratory detection and testing technologies. Her experience includes investigating genetic modifiers of cardiovascular disease, studying how mitochondrial and metabolic dysfunction impacts outcomes in heart failure, and developing novel extracellular antibody-drug conjugate (EDC) approaches for cancer therapy.